Performance of Acceleromyography With and Without Preload
Phase 4
Completed
- Conditions
- Neuromuscular Blockade
- Interventions
- Device: Hand Adapter (Organon, Oss, the Netherlands)Device: Placebo
- Registration Number
- NCT00226018
- Lead Sponsor
- Rigshospitalet, Denmark
- Brief Summary
The purpose of this study is to examine the precision, bias and limits of agreement when monitoring the neuromuscular block with acceleromyography with and without preload and compare the method to the gold standard, mechanomyography.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- ASA I-III
- General anesthesia > 1 hour
- Surgery under supine position with possibility of monitoring the neuromuscular block in both arms (thumbs)
- Written informed content
Exclusion Criteria
- Neuromuscular disorders, hepatic and renal dysfunction
- Medication expected to interfere with the neuromuscular blocking agent
- Allergy to any medication used during anesthesia
- Body weight less or exceeding 20% of the ideal body weight
- Pregnancy or breastfeeding
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 Hand Adapter (Organon, Oss, the Netherlands) Acceleromyography with Hand Adapter on dominant arm 2 Hand Adapter (Organon, Oss, the Netherlands) Acceleromyography with Hand Adapter on non-dominant arm 3 Placebo Acceleromyography without Hand Adapter on dominant arm 4 Placebo Acceleromygraphy without Hand Adapter on non-dominant arm
- Primary Outcome Measures
Name Time Method The precision of acceleromyography with and without preload during recovery
- Secondary Outcome Measures
Name Time Method Bias and limits of agreement for acceleromyography (AMG) with and without preload compared to mechanomyography (MMG) during recovery All the following outcomes obtained with AMG with and without preload are compared to MMG. Furthermore the responses are compared when the AMG-values are "normalized": Bias og limits of agreement between control TOF Onset time Time to reappearance of T1, T2, T3 and T4 Twitch height of T1 at reappearance of T1, T2, T3 and T4 Time to T1=25% Interval 25-75% Time to TOF-ratio = 0.9 and 1.0 Time to final T1 Time to final TOF ratio
Trial Locations
- Locations (1)
Dep. of anesthesia, HOC, Rigshospitalet
🇩🇰Copenhagen, Copenhagen Ø, Denmark